Cabinet Clears KKR's $400 Million Investment In India Drug Makers
This article was originally published in PharmAsia News
Executive Summary
India's cabinet ended a dispute among several ministries and cleared U.S.-based KKR to invest $400 million in in a three-way deal to acquire existing pharma-related businesses.